Biocon Biologics report explores pathways to increase biosimilar adoption in low- and middle-income countries Read more
Biocon Biologics successfully integrates acquired biosimilars business across 120 countries Read more
Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData Read more